Mario Masarone

4.9k total citations · 1 hit paper
93 papers, 2.9k citations indexed

About

Mario Masarone is a scholar working on Epidemiology, Hepatology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Mario Masarone has authored 93 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Epidemiology, 41 papers in Hepatology and 15 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Mario Masarone's work include Liver Disease Diagnosis and Treatment (55 papers), Hepatitis C virus research (31 papers) and Hepatitis B Virus Studies (18 papers). Mario Masarone is often cited by papers focused on Liver Disease Diagnosis and Treatment (55 papers), Hepatitis C virus research (31 papers) and Hepatitis B Virus Studies (18 papers). Mario Masarone collaborates with scholars based in Italy, United States and Spain. Mario Masarone's co-authors include Marcello Persico, Alessandro Federico, C. Loguercio, Marcello Dallio, Valerio Rosato, Andrea Aglitti, Antonietta Gerarda Gravina, Ludovico Abenavoli, Savino Bruno and Roberto Torella and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Hepatology.

In The Last Decade

Mario Masarone

88 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease

2018 528 citations Mario Masarone, Valerio Rosato et al. Oxidative Medicine and Cellular Longevity profile →

Peers

Countries citing papers authored by Mario Masarone

Since Specialization

Citations

This map shows the geographic impact of Mario Masarone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mario Masarone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mario Masarone more than expected).

Fields of papers citing papers by Mario Masarone

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mario Masarone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mario Masarone. The network helps show where Mario Masarone may publish in the future.

Co-authorship network of co-authors of Mario Masarone

This figure shows the co-authorship network connecting the top 25 collaborators of Mario Masarone. A scholar is included among the top collaborators of Mario Masarone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mario Masarone. Mario Masarone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Metabolic associated steatotic liver disease in renal transplant recipients: a retrospective cohort study 2025 ·Internal and Emergency Medicine ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Mario Masarone, Marcello Persico, Giancarlo Bilancio	0
2	Gut–Liver Axis Dysregulation in Portal Hypertension: Emerging Frontiers 2024 ·Nutrients ·Martina Lombardi, Jacopo Troisi, Benedetta Maria Motta, (unknown), Mario Masarone, Marcello Persico	12
3	Country-Wide HCV Elimination Strategies Need to Reach Older Patients in the General Population: The Italian Experience 2023 ·Viruses ·(unknown), (unknown), Mario Masarone, Marcello Persico	2
4	From Non-Alcoholic Steatohepatitis (NASH) to Hepatocellular Carcinoma (HCC): Epidemiology, Incidence, Predictions, Risk Factors, and Prevention 2023 ·Cancers ·Benedetta Maria Motta, Mario Masarone, (unknown), Marcello Persico	25
5	Nutrigenomics and Nutrigenetics in Metabolic- (Dysfunction) Associated Fatty Liver Disease: Novel Insights and Future Perspectives 2021 ·Nutrients ·Marcello Dallio, Mario Romeo, Antonietta Gerarda Gravina, Mario Masarone, Tiziana Larussa, Ludovico Abenavoli, Marcello Persico, C. Loguercio, Alessandro Federico	19
6	The Role of Fructose in Non-Alcoholic Steatohepatitis: Old Relationship and New Insights 2021 ·Nutrients ·Alessandro Federico, Valerio Rosato, Mario Masarone, (unknown), Marcello Dallio, Mario Romeo, Marcello Persico	50
7	The Role of Resveratrol in Liver Disease: A Comprehensive Review from In Vitro to Clinical Trials 2021 ·Nutrients ·Carmine Izzo, (unknown), (unknown), (unknown), Marcello Dallio, Mario Masarone, Alessandro Federico, Marcello Persico	90
8	The Bisphenol A Induced Oxidative Stress in Non-Alcoholic Fatty Liver Disease Male Patients: A Clinical Strategy to Antagonize the Progression of the Disease 2020 ·International Journal of Environmental Research and Public Health ·Alessandro Federico, Marcello Dallio, Antonietta Gerarda Gravina, Nadia Diano, (unknown), Mario Masarone, Mario Romeo, Concetta Tuccillo, Paola Stiuso, Filomena Morisco, Marcello Persico, C. Loguercio	21
9	NAFLD and Extra-Hepatic Comorbidities: Current Evidence on a Multi-Organ Metabolic Syndrome 2019 ·International Journal of Environmental Research and Public Health ·Valerio Rosato, Mario Masarone, Marcello Dallio, Alessandro Federico, Andrea Aglitti, Marcello Persico	104
10	Chemical Effect of Bisphenol A on Non-Alcoholic Fatty Liver Disease 2019 ·International Journal of Environmental Research and Public Health ·Marcello Dallio, Nadia Diano, Mario Masarone, Antonietta Gerarda Gravina, (unknown), Mario Romeo, (unknown), (unknown), Carla Nicolucci, Ludovico Abenavoli, Emidio Scarpellini, Luigi Boccuto, Marcello Persico, C. Loguercio, Alessandro Federico	50
11	Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients 2019 ·Oxidative Medicine and Cellular Longevity ·Alessandro Federico, Marcello Dallio, Mario Masarone, Antonietta Gerarda Gravina, (unknown), Concetta Tuccillo, Valentina Cossiga, Stefania Lama, Paola Stiuso, Filomena Morisco, Marcello Persico, C. Loguercio	55
12	Pressure support ventilation vs Continuous positive airway pressure for treating of acute cardiogenic pulmonary edema: A pilot study 2018 ·Respiratory Physiology & Neurobiology ·Antonio Pagano, Fabio Giuliano Numis, Valerio Rosato, Teresa Russo, Giovanni Porta, Giorgio Bosso, (unknown), Mario Masarone, (unknown), Fiorella Paladino	5
13	Qualitative and Quantitative Evaluation of Dietary Intake in Patients with Non-Alcoholic Steatohepatitis 2017 ·Nutrients ·Alessandro Federico, Marcello Dallio, (unknown), Antonietta Gerarda Gravina, (unknown), Mario Masarone, Marcello Persico, C. Loguercio	18
14	Endocan Serum Levels in Patients with Non-Alcoholic Fatty Liver Disease with or without Type 2 Diabetes Mellitus: A Pilot Study 2017 ·Journal of Gastrointestinal and Liver Diseases ·Marcello Dallio, Mario Masarone, (unknown), (unknown), Concetta Tuccillo, Ferdinando Carlo Sasso, Marcello Persico, C. Loguercio, Alessandro Federico	21
15	“Non alcoholic fatty liver disease and eNOS dysfunction in humans” 2017 ·BMC Gastroenterology ·Marcello Persico, Mario Masarone, Antonio Damato, Mariateresa Ambrosio, Alessandro Federico, Valerio Rosato, Tommaso Bucci, Albino Carrizzo, Carmine Vecchione	49
16	Alcoholic Liver Disease and Hepatitis C Chronic Infection 2016 ·Reviews on Recent Clinical Trials ·Alessandro Federico, Marcello Dallio, (unknown), Ludovico Abenavoli, Mario Masarone, Marcello Persico, C. Loguercio	5
17	The effect of antiviral therapy on hepatitis C virus-related thrombocytopenia: a case report 2014 ·BMC Research Notes ·(unknown), Valerio Rosato, Mario Masarone, Marco Romano, Marcello Persico	5
18	The Impact of Diet on Liver Fibrosis and on Response to Interferon Therapy in Patients With HCV-Related Chronic Hepatitis 2008 ·The American Journal of Gastroenterology ·C. Loguercio, Alessandro Federico, Mario Masarone, Roberto Torella, C. Del Vecchio Blanco, Marcello Persico	16
19	The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis 2006 ·Digestive and Liver Disease ·Bruno Palmentieri, (unknown), Vincenzo La Mura, Mario Masarone, Raffaella Vecchione, Savino Bruno, Roberto Torella, Marcello Persico	284
20	Hepatitis C virus carriers with persistently normal ALT levels: biological peculiarities and update of the natural history of liver disease at 10 years 2005 ·Journal of Viral Hepatitis ·Marcello Persico, Silverio Perrotta, Eliana Persico, Luigi Terracciano, Antonella Folgori, Lionello Ruggeri, Alfredo Nicosia, Raffaella Vecchione, Vincenzo La Mura, Mario Masarone, Roberto Torella	41

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact